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Abstract
Background: In humans, analysis of amniotic fluid is widely used for diag-
nostic and prognostic purposes. Amniocentesis has scarcely been used in
veterinary medicine to date, despite a tremendous potential for clinical and
research applications in dogs. Our study aimed to establish a safe method for
foetal fluid sampling in female dogs.
Methods: Two transabdominal ultrasound-guided methods were assessed:
the “free hand” and the needle-guided bracket sampling. In addition, through
a subsequent routinely scheduled ovariohysterectomy, fluid was directly col-
lected. Samples from 98 conceptuses were collected at day 46.7 ± 7.5 of preg-
nancy.
Results: The amount of fluid retrieved varied between 0.5 and 5.0 ml per col-
lection. Macroscopic examination of the uterus and conceptuses identified
53% of the puncture sites. Neither fluid leakage nor foetal injury was detected,
and six hematomas (5.8%) were visible. Ultrasound-guided foetal fluid collec-
tion was found to be potentially safe, and it can be performed by using either
transabdominal method.
Conclusion: Foetal fluid collection is possible with relative ease and low
short-term risk, and may open paths for diagnostic, therapeutic and research
purposes in dogs. The procedure can provide new insights into prenatal clin-
ical medicine, including diagnostics of foetal deaths, early identification of
heritable diseases and so on.
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INTRODUCTION
The foetal membranes of the canine species are the
allantois, amnion, chorion and yolk sac.1 The amniotic
cavity provides mechanical protection of the fetus and
its development in a liquid medium.2 Amniotic fluid
is a complex biofluid which provides both mechani-
cal and antimicrobial protection to the fetus as well
as lubrication, nutrition and growth factors, which are
important for foetal development.3 Amniotic fluid is
formed with contributions from oral, nasopharyngeal,
tracheal, pulmonary secretions and urine excretion
from the conceptus.4
Amniocentesis is a technique for collecting amni-
otic fluid from the amniotic sac. The technique is per-
formed using a needle via transabdominal centesis
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and under continuous ultrasound guidance.5 In
humans and other primates, the allantois regresses
very early in development to remain at term as a diver-
ticulum enclosed into the wall of the umbilical cord.2
Therefore, during amniocentesis it is possible to col-
lect amniotic fluid solely. The main purposes for per-
forming amniocentesis are for ante-partum assess-
ment of foetal viability and detection of diseases.6–8
Analysis of amniotic biofluid is used extensively in
human clinical medicine for diagnosis of chromoso-
mal abnormalities or single gene disorders, as well as
the evaluation of foetal lung maturity, microbial inva-
sion of the amniotic cavity, intra-amniotic inflamma-
tion, foetal infections and gender determination.9–11
In carnivores and ungulates, the allantoic sack
grows to line the chorionic sack almost entirely and
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persist until parturition. It communicates with the uri-
nary apparatus of the fetus and acts as waste reser-
voir of foetal metabolism.2 As a result, foetal fluid is
potentially available for collection from both amni-
otic and allantoic cavities. It can be assumed that
an amniocentesis is feasible in the female dog in a
time frame beginning at the second half of pregnancy
and onwards, as there is sufficient foetal fluid and
the amniotic and allantoic membranes are discern-
able. Few studies on foetal fluid analysis in cattle and
horses have indicated their use for diagnosis of infec-
tious diseases,12,13 gender determination,14 as well as
assisted reproductive techniques such as production
of cloned offspring.15 In dogs, one study analyzed the
amniotic fluid for determining pulmonary maturity in
the last days of pregnancy,16 and another case study
showed the feasibility of performing sex analysis from
amniotic cells of a singleton canine pregnancy.17 In
addition, puncture of amniotic or allantoic cavities
have been used in the canine species to inject agents
for research purposes,18,19 gene therapy and induction
of abortion.20
In human medicine, well-established standard pro-
cedures for amniocentesis have been developed in
the past decades.7,21 Amniocentesis is commonly per-
formed in the second trimester, which is from 16 weeks
of pregnancy onwards.21 It carries a risk of foetal loss
of approximately 0.5% (range, 0.06−1%) when per-
formed in the second trimester. In addition, a risk
of amniotic fluid leakage in approximately 0.3% of
cases and other rare complications such as placen-
tal haemorrhage, intra-amniotic infection, abdom-
inal wall hematoma and foetal lesion have been
described.9 Guidelines for the procedure include the
positioning of the woman, the skin preparation prior
to puncture, the preceding ultrasound evaluation, the
position of the ultrasound probe, needle insertion,
uterine puncture, amniotic fluid aspiration and post
procedure recommendations.9
As of today, the procedures for fluid collection16,17 or
injection of substances into foetal cavities in dogs18–20
were not described in abundant detail, especially
in regard to the potential complications and side
effects. Therefore, no routine method has been devel-
oped, and no safety studies have been performed to
date.
The aim of our study was to establish a method of
foetal fluid sampling in the female dog, as well as to
assess safety aspects of the methodology.
MATERIALS AND METHODS
Animals
Foetal fluid collection was performed on a cohort of
21 healthy pregnant female dogs representing five
breeds (Bull Terrier, Asian Shepherd, Golden Retriever,
Labrador Retriever and Cavalier King Charles Spaniel;
one female dog per breed) and 16 mongrel female
dogs. All were pregnant stray dogs that were brought
to the Hebrew University Veterinary Teaching Hospital
(HUVTH) for preterm ovariohysterectomy. Estimated
ages were provided by the authority that held them
for most but not all of the dogs (Table 1). This infor-
mation was based on rabies vaccine federal records.
Ovariohysterectomy is a routine procedure in preg-
nant stray animals advocated by the Society for
Prevention of Cruelty to Animals (SPCA) in Israel,
aiming to prevent overpopulation in the country
(https://spca.co.il/spaying-neutering/). The proce-
dure was conducted by board-certified theriogenolo-
gist and anaesthetists from the HUVTH. Furthermore,
this study was approved by the HUVTH Committee
of Animal Handling and Experimentation (permit
KSVM-VTH/08_2015).
Determination of cycle stage and ovulation timing
was performed on none of the dogs prior to concep-
tion. In addition, no information on the reproductive
history of the animals was available.
Examination of female dogs
Prior to foetal fluid sampling, each female dog
underwent a complete general and gynaecological
examination including vaginoscopy, vaginal cytol-
ogy and abdominal ultrasound. As a part of rou-
tine pre-surgical tests, blood samples were collected
in potassium-EDTA tubes used for complete blood
count (CBC; Advia 120; Siemens Medical Solutions
Diagnostics, Erfurt, Germany), and in plain tubes, for
serum creatinine measurements using an autoana-
lyzer (Cobas-Integra 400 Plus, Roche, Mannheim, Ger-
many, at 37◦C). Only female dogs showing no signs of
disease were enrolled into the study. All female dogs in
the study were considered healthy based on their clin-
ical and gynaecological exams, and based on their lab-
oratory test results.
Gestational age was assessed by measuring bipari-
etal head diameters (BPD) of at least three foetuses
(with the exception of one female dog that carried
only two foetuses) using ultrasonography (Mindray
M9, Shenzhen Mindray Bio-medical Electronics, Co.,
Shenzhen, China, with an C11-3s micro convex 3–
11 MHz transducer). Average BPDs were measured and
days to parturition were calculated using the follow-
ing formulas: (BPD in mm – 29.18)/0.7 for medium
(10–20 kg) and large (over 20 kg) size female dogs and
(BPD in mm – 25.11)/0.61 for small (2–10 kg) female
dogs.22 Based on this calculation, all foetal fluid collec-
tion procedures aimed to be performed between day
35 and on post ovulation.
Anaesthesia
All female dogs were premedicated with methadone
(Physeptone; Martinadale pharmaceuticals, Brent-
wood, UK) 0.5 mg/kg IM 30 min prior to the pro-
cedure. Acepromazine (acepromazine 0.1%; Medi-
market, Netanya, Israel) 0.01–0.03 mg/kg IM and
atropine (atropine sulphate; Teva Pharmaceutical
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1 3 Bull Terrier 20 S 6 3 (3FH) 1L + 2R
2 2.5 Mixed breed 25 40 5 5 (2FH; 3G) 2L + 3R
3 2 Mixed breed 8 56 3 1 (1FH) 1B
4 2 Mixed breed 22.4 S 6 6 (2FH; 4G) 2L + 3R + 1B
5 4 Mixed breed 22.6 50 5 3 (1FH; 2G) 2R +1B
6 Young Mixed breed 8,4 53 2 2 (2G) 1L + 1R
7 Mature Mixed breed S 45 4 3 (2FH; 1G) 1L + 1R + 1B
8 2 Mixed breed 22.5 52 4 2 (2FH) 1R + 1B
9 Mature Mixed breed 20 50 5 3 (3G) 1L + 1R + 1B/L
10 Young mature Mixed breed 6.6 38-40 6 6 (3FH; 3G) 3L + 2R + 1B
11 1.5 Mixed breed 30 49 9 6 (1FH; 5G) 4L + 2R
12 1.2 Asian Shepherd 46 43 8 4 (2FH; 2G) 3L + 1R
13 1 Mixed breed 20.7 44 7 7 (2FH;5G) 2L + 3R + 2B
14 5.2 Mixed breed 18.2 45 7 5 (3FH; 2G) 1L + 2R + 2B
15 2.25 Mixed breed 23 42 8 6 (3FH; 3G) 2L + 1R + 3UN
16 Mature Mixed breed 30 47 10 7 (2FH; 5G) 2L + 5R
17 5.6 Mixed breed 12 35 7 7 (3FH; 4G) 3L + 4R
18 5.8 Golden Retriever 41.6 62 4 2 (2G) 1L + 1R
19 2 Labrador Retriever 15 50 8 8 (3FH; 5G) 4L + 4R
20 2.8 Mixed breed 42 35 7 7 (4FH; 3G) 3L + 4R
21 8.2 Cavalier King
Charles Spaniel
10 50 6 5 (1FH; 4G) 1L + 3R + 1B
Ultrasound-guided fluid collection performed on 98 canine foetuses to assess short-term safety of the procedure at day 46.7± 7.5 (range 35–62 days) of pregnancy.
*Estimated age in years; S = missing data; FH = using free hand technique; G = using needle guide; L = left horn; R = right horn; B = body of the uterus;
UN = unknown area of collection.
**The location was determined using ultrasonography and therefore not confirmed.
Industries Ltd, Debrecen, Hungary) 0.02 mg/kg IM
were administered as needed, based on temperament
and baseline heart rate of the female dog. Female
dogs were induced with propofol (Lipuro 1%; B. Braun
M1elsungen AG, Melsungen, Germany) IV to effect
(0.5–1.5 mg/kg) and diazepam (Assival; Teva Phar-
maceutical Industries, Netanya, Israel) 0.5 mg/kg IV.
Anaesthesia was maintained with isoflurane (Ter-
rell Isoflurane USP; Piramal Critical Care Inc., Beth-
lehem, PA) in 100% oxygen. During anaesthesia
patients were monitored for heart rate and res-
piratory rate using lead II electrocardiogram and
pulse oximetry. Additional monitoring during anaes-
thesia included oesophageal temperature measure-
ments, end tidal CO2 monitoring (S/5 monitor; Datex
Ohmeda, Helsinki, Finland) and noninvasive blood
pressure measurements using a Doppler technique
(811-BTS; Parks Medical Electronics, Beaverton, OR)
or oscillometry (Cardell 9601; Midmark Corp., Miamis-
burg, OH). A forced-air warming device (Thermacare;
Gaymar Industries Inc., Orchard Park, NY) was applied
to minimize heat loss.
Once the patient was fully anesthetized and mon-
itored, the abdomen was clipped and disinfected
using povidone iodine surgical scrub solution and 70%
ethanol solution.
Percutaneous foetal fluid sampling
Two methods were performed using a disposable
spinal needle (18 G x 3½ inch or 21 G x 3½ inch, KDL,
London, UK):
1. “Free hand technique” – without a needle guide.
Prior to insertion of the spinal needle the abdomen
was disinfected once more, using 70% ethanol. The
uterine and gestational cavities, as well as the fetus,
were examined via ultrasonography, and an opti-
mal collection position that appeared promising
for fluid collection without harming the fetus or
the foetal membranes was selected. At the same
time, the localization of the fetus in the left or right
uterine horn and the collection site (allantois or
amnion) were estimated, even if this method may
not be completely reliable. Then, the spinal nee-
dle was inserted into the abdominal wall in an
almost 90◦ angle and advanced into the uterine
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F I G U R E 1 Transabdominal fetal fluid collection using an
ultrasonography needle-guided brackets
cavity and the gestational sac (amnion or allantois).
Both amniotic and allantoic membranes were often
visible but a definite positioning of the tip of the
needle was not always possible. When the needle
was positioned, fluid was aspirated using a 5-ml
syringe. The collected fluid was immediately trans-
ferred to a sterile 1.5-ml Eppendorf tube and frozen
at −80◦C.
2. Using an ultrasonography needle-guided brackets
(model BGB-018; Shenzen Mindray Bio- Medical
Electronics, Co., Shenzen, China), i.e. a needle guid-
ing device, which can be attached to the C11-3s
curved array transducer. Prior to each procedure,
the guide underwent sterilization in an autoclave.
After sampling of each gestational sac, it was disin-
fected using 70% ethanol. The guide was placed on
the probe according to the manufacturer’s instruc-
tions, and the spinal needle inserted into a small
hole in a preset position on the guide, as shown in
Figure 1. Penetration of the foetal membranes, fluid
collection and its processing followed the same
procedures described for the “free hand technique”.
Both techniques were used on 15 female dogs
(Table 1). For each female dog, fluid was collected
from a minimum of one foetus from the left horn, one
from the right horn and one from the uterine body,
if this was possible within a few minutes, i.e. if there
were more than two foetuses in a pregnancy, and if the
position of the foetus allowed for safe fluid collection
(Table 1).
Foetal fluid sampling during surgery
After the percutaneous sampling, the abdomen was
scrubbed again with povidone iodine scrub solution
and 70% ethanol solution in preparation for surgery.
F I G U R E 2 Collection of fetal fluids during surgery using a
spinal needle
Laparotomy was then performed commencing with
an incision in the linea alba. The uterine wall was
inspected for lesions and puncture holes from the
percutaneous samplings. The uterus was then incised
near the cranial or caudal end of each gestational sac,
with care taken not to incise over a placenta. The allan-
toic and amniotic membranes were inspected thor-
oughly for lesions and puncture signs from percuta-
neous sampling. An 18-gauge hypodermic needle used
for female dogs weighing up to 25 kg, or a 21-gauge
needle for female dogs weighing more than 25 kg,
respectively, was then inserted through the membrane
and fluid was collected for analysis using a 3- or 5-ml
syringe (Figure 2). Using both methods, percutaneous
and surgical foetal fluid collection, care was taken not
to injure the conceptus itself.
Following termination of foetal fluid samplings from
the different conceptuses, routine ovariohysterectomy
was performed, and the foetuses euthanized individ-
ually immediately after removal of the uterus with
an intracardiac injection of pentobarbital sodium
solution, 150 mg/kg IP (Pental Veterinary Injection
200 mg/ml; CTS Chemical Industries Ltd., Israel) . After
termination of the surgery and routine abdominal clo-
sure, 25 mg/kg dipyrone (Optalgin, Teva Pharmaceu-
tical Industries, Israel) was administered SQ for pain
management.
Evaluation of foetal fluid was performed macro-
scopically and specific gravity was determined using a
refractometer (Headed Reinforcement Corp., Fountain
Valley, CA).
Statistical analyses of the results were performed by
IBM SPSS Statistics software (version 24 for Windows).
Frequency analysis, cross tables, Pearson chi-squared
test and Pearson correlation test were used to deter-
mine differences between the expected and observed
frequencies of total number and sampled foetuses for
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the age, body weight and day of pregnancy. The signif-
icance level was set as α = 0.05.
RESULTS
The duration of the foetal fluid collection procedure
prior to ovariohysterectomy took up to 15 min, and the
whole surgery time did not exceed 60 min.
Foetal fluid was successfully collected from 98
foetuses of all 21 female dogs (Table 1). Detailed
information on the dogs, their estimated age, day
of pregnancy, number and localization of sampled
amniotic fluid can be found in Table 1. The mean age
of female dogs for which the age could be estimated
(n = 16) was 3.19 ± 2.39 years (range 1–8.2 years). The
age of five female dogs could not be determined. The
mean body weight (n = 20) was 22.2 ± 10.8 kg (range
6.6–46.0 kg) excluding the weight of one female dog
due to recording errors.
Fluid collection was conducted from 98 foetuses on
day 46.7 ± 7.5 of pregnancy (range 35–62 days). The
mean number of conceptuses sampled per female dog
(n = 21) was 4.7 ± 2.1 (range 1–8 conceptuses). Foetal
fluid from 40 foetuses was collected using the free
hand technique, and from 58 foetuses it was collected
using the needle-guided method. Foetuses sampled
were located on both the left (n= 37) and right (n= 46)
uterine horns, and in the uterine body (n = 11). The
location of three of the foetuses was not determined
precisely by ultrasonography.
The amount of fluid retrieved from each concep-
tus ranged between 0.5 and 5.0 ml. During most col-
lections, however, sampling was stopped as soon as
a volume of 3.0 ml was reached to avoid harming
the foetuses. The colour of the foetal fluid retrieved
was mostly transparent, or yellowish transparent. Two
samples were yellowish, one was reddish and one was
greyish in colour, and 23 of the samples were cloudy.
The viscosity was low in all cases, and the specific
gravity ranged between 1.002 and 1.016 in all samples
(mean 1.009 ± 0.009).
In total, 55 out of the 98 puncture sites were iden-
tified macroscopically on the uterine serosal surface
(Figure 3). In two female dogs, hematomas measur-
ing approximately 2 and 3 ml in diameter were found
at one puncture site, respectively (Figure 4). Spon-
taneous fluid leakage was not observed from any of
the puncture sites. This was ascertained by using
gentle digital pressure on the uterine wall around
the puncture sites. Careful examination of the mem-
branes of every fetus immediately after its exposi-
tion revealed that in 30 out of 98 a small puncture
site could be detected macroscopically. The diame-
ter of all puncture sites, as measured by a caliper,
was less than 0.5 mm. In six out of the identified
30 puncture sites, a small external hematoma of less
than 0.5 cm was present on the foetal membrane
surfaces.
During the surgical procedure, foetal membranes
of three conceptuses ruptured spontaneously due to
handling. Finally, the skin of each of the 98 foetuses
F I G U R E 3 Puncture site on the serosal surface of the uterus
after transabdominal fetal fluid sampling. No fluid leakage was
noticed. The puncture site is demarcated by a black circle
F I G U R E 4 Hematoma on a puncture site on the serosal sur-
face of the uterus after transabdominal fetal fluid sampling. No fluid
leakage was noticed. The hematoma is demarcated by a black circle
was examined immediately after removal from the
foetal membranes. Not a single puncture site or signs
of injury were identified.
Only one percutaneously collected sample was of
red colour, presumably blood. However, the corre-
sponding area of the uterus, the foetal membranes and
the fetus did not show any signs of injury.
Statistical analysis revealed that there was no sig-
nificant influence of the dam’s body weight on the
total number of foetuses (p = 0.13) or on the num-
ber of foetuses sampled (p = 0.80). Also, the age of the
dam had no influence on these numbers (p = 0.43 and
p = 0.71). Furthermore, the bodyweight and the day of
pregnancy at the time of sampling had no influence
on the proportion of foetuses (number of sampled foe-
tuses/total number of foetuses) sampled (p = 0.6 and
p = 0.15, respectively).
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DISCUSSION
The main conclusion from this study is that percuta-
neous foetal fluid collection between days 35 and 62
from ovulation via centesis causes only little visible
damage to the uterus, the extraembryonic membranes
and the fetus. Pending future studies on long-term
safety, the procedure may be considered as a routine
method, with minimal injury. In accordance with our
hypothesis, we can confirm that in less than 10% of
sampling punctures in the uteri and conceptuses,
clinically relevant signs of injury were detected. Even
when macroscopically puncture sites in the uterus
could be seen in half of the samples and in around
one-third of foetal membranes, no fluid leakage and
no lesions in the skin of the foetuses were detected.
The feasibility and safety of the procedure has also
been shown by Bonte et al.16 Spinal needle puncture
sites were visible in 30% of the foetal membranes but
most seemed not to be of clinical relevance. While sev-
eral studies in humans showed the rate of fluid leakage
due to amniocentesis procedure to be 1.4–1.6%,23,24
in our study we observed no fluid leakage from any
puncture site. Furthermore, small hematomas on the
foetal membranes were found at only six puncture
sites (5.8%) with no injury noted on the skin of any
foetus sampled. These findings are based on a cohort
of 98 samples and for the detection of side effects with
low incidences, a higher number of samples may have
been helpful to calculate more robust percentages of
fluid leakages and hematomas.
Potential complications of amniocentesis in human
medicine include infection of the amniotic sac,
preterm labour, respiratory distress, foetal deformities,
trauma, alloimmunisation and failure of the puncture
wound to heal properly.25 Although very uncommon
in human medicine, foetal injury can occur secondary
to trauma from the needle. Foetal trauma case reports
have commonly reported disfigurements on the skin;
nonetheless, cases have been reported inciting direct
trauma to central nervous system causing bleeding,
ocular disturbances and injury to internal organs.26–28
In our study, exploratory laparotomy and observa-
tion of tissues and foetuses were all performed within
60 min after the amniocentesis procedure. Although
no foetal injury was detected macroscopically follow-
ing needle puncture, it is possible that microscopic
injuries did occur. It is possible that some microscopic
puncture sites in the uterus, foetal membranes or foe-
tuses may have not been identified. For these cases,
it can be assumed that they would not have been of
clinical relevance. Further studies, with a larger cohort
and a follow-up to an examination of newborn pup-
pies postpartum are required in order to evaluate the
possible long-term effects of foetal fluid centesis pro-
cedure on the canine pregnancy, and on the sampled
offspring.
Foetal fluids were collected from all pregnant female
dogs enrolled in this study. However, using the trans-
abdominal fluid collection methods, it was not possi-
ble to take samples from all gestational sacs of each
pregnant female dog. In some cases, especially when a
high number of conceptuses was present in the uterus,
a definitive determination of the different gestational
sacs was not always possible ultrasonographically. In
addition, the gravid uterine horns were convoluted in
many female dogs, and parts of them crossed over
from left to right and vice versa in the abdominal cav-
ity, which added a challenge in locating the exact posi-
tion of each conceptus.
When interpreting the results of the statistical anal-
ysis, one has to take into account that the sample size
and the high variations among the female dogs do not
allow concise conclusions. The volume of foetal fluid
that can be collected may have depended on the size
of the dam, the stage of the pregnancy, the number
of conceptuses in the uterus, and their position in the
abdomen, as well as on the level of proficiency of the
person collecting the samples. However, in this study
we did not assess these influencing factors since we
stopped fluid collection in most cases when 3.0 ml was
aspirated. A volume of 1.0 ml is suitable for one or
more diagnostic tests16 and collecting more fluid than
necessary might increase the risk of injury.
Between 35 and 62 days post ovulation there is suffi-
cient fluid in the gestational sac, and the foetus does
not impede the collection procedure. Based on the
statistical analysis, the day of sampling had no influ-
ence on the proportion of foetuses that could be sam-
pled. In the time period we chose, the space in the
gestational sac is sufficient for safe insertion of the
tip of a spinal needle without injuring the concep-
tus. We hypothesize that prior to day 35 post ovula-
tion, the amount of foetal fluids is not abundant, and
it can be assumed that the potential risk for injur-
ing the conceptus is higher. It is expected that foetal
fluid collection via needle puncture from this time on
to the end of the pregnancy is safe to the conceptus.
This is in accordance with another study that showed
no complications to either the dam or the concep-
tuses following the collection of amniotic fluids 1 day
prepartum.16
Two methods were used in the current study to col-
lect amniotic fluids: with and without needle-guided
brackets. It was concluded subjectively that the use of
a needle guiding device facilitated the visualization of
the needle and puncture of the gestational sac cavity.
The free hand method, however, enabled a more flexi-
ble handling of the needle and adjustment of the path
of needle insertion. Initially, it was significantly eas-
ier to perform the procedure using the ultrasonogra-
phy needle-guided brackets. As experience was gained
during this study, after performing numerous foetal
fluid collections, the ability to use both methods inter-
changeably was achieved. The same outcomes were
gained for amounts of foetal fluid retrieval. The inci-
dence of injuries was low for both procedures. In order
to prove one method safer than the other, a larger set
of observations is necessary. It is likely that the nee-
dle bracket guide may be easier and safer in the hands
of beginner and less experienced operators for foetal
fluid collection from pregnant dogs. These observa-
tions are in accordance with human literature and
practice. In human medicine, most operators prefer
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the “freehand technique”, i.e., without the aid of a nee-
dle guiding device. However, beginner operators often
use needle guides until they are comfortable with the
procedure.29,30 The drawback of using the ultrasound
needle-guided brackets in this study is the need for
sterilization of the apparatus between multiple foetal
fluid samplings of different conceptuses in one female
dog during one procedure. Bathing the apparatus in
70% ethanol solution between sampling procedures
is not optimal, as it potentially carries a higher risk
of contamination of conceptuses, despite the use of a
new sterile spinal needle. Hence, it would be optimal
to have several guides to be able to use a sterile guide
for each fluid collection.
Prenatal cell-free DNA screening from maternal
blood samples, or non-invasive prenatal DNA test-
ing (NIPT), is an important addition to the range of
screening tests for foetal chromosomal abnormalities
in humans,30 and can also be used for sex determina-
tion in bovines.31 Prenatal screening in the dog using
NIPD has not been established to date, as, unlike the
human and cattle, it is a polytocous species.32
Foetal fluid sampling may be used in the future in
dogs for screening for hereditary diseases, metabolic,
toxic and various other conditions or in terms of
genetic, genomic and epigenetic foetal tissue and cel-
lular manipulations, or for sex determination. In addi-
tion, in utero injections of therapeutic agents may be
a potential clinical tool in canine medicine. In the
research context, also the safety of medications given
to the dam for the conceptus may be examined by
foetal fluid sampling.
Collection of foetal fluids from dogs can also be
valuable as a source of stem cells with therapeutic
potential in the field of regenerative medicine. Stem
cells from the amniotic fluid can be isolated and
expanded easily,33 and have the ability to differentiate
into a various cell types without the risk of tumorige-
nesis. These cells can successfully engraft in multiple
organs, and emerging evidence from experimental
models of disease has generated great interest in
potential clinical applications for human tissue repair
and regeneration. The latter, in combination with
the lack of ethical concerns associated with other
stem cell sources, such as ovine34,35 and leporine,36
makes stem cells derived from the foetal fluids prime
candidates for the development of novel therapies for
a wide range of congenital and acquired human and
animal disorders.37
The collection of foetal fluid may provide valu-
able possibilities for veterinary research in the canine
species, as well as for clinical practice, including iden-
tification of heritable diseases, especially those that
are lethal, identification of sex related diseases and so
on. To date, the literature on foetal fluid analysis in
the female dog is scarce and focuses on sample collec-
tion close to term. One example is the study on foetal
pulmonary maturity in dogs using amniotic fluid col-
lected in the last days of pregnancy.16 Another study
characterized progenitor stem cells from allantois and
amniotic fluids at the third trimester of gestation in
the female dog.38 A third example is a case report
reported foetal in a singleton pregnancy in a dog.17
All three studies used percutaneous collection of flu-
ids. In other studies, at which foetal fluid was collected,
the latter was performed post surgically (for example,
cesarean section or ovariohysterectomy of pregnant
female dogs at term).39,40
CONCLUSION
Ultrasound-guided foetal fluid collection is a poten-
tially safe procedure, and in the hands of the trained
operator can be executed with relative ease by using
either the “freehand technique” or needle-guided
methodology. The option to collect canine foetal flu-
ids with relative ease and a low risk of immediate side
effects opens up a path to use them for diagnostic,
therapeutic and research purposes, similar to the way
it is performed in humans. Further research is war-
ranted to assess long-term safety of the procedure.
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